
### [NCIT:C7580](http://purl.obolibrary.org/obo/NCIT_C7580)
**Label:** Skin Appendage Adenoma

**Subclasses:** [NCIT:C40312](http://purl.obolibrary.org/obo/NCIT_C40312) (Vulvar Nodular Hidradenoma), [NCIT:C4168](http://purl.obolibrary.org/obo/NCIT_C4168) (Apocrine Adenoma), [NCIT:C7568](http://purl.obolibrary.org/obo/NCIT_C7568) (Nodular Hidradenoma), [NCIT:C7567](http://purl.obolibrary.org/obo/NCIT_C7567) (Clear Cell Hidradenoma), [NCIT:C7563](http://purl.obolibrary.org/obo/NCIT_C7563) (Hidradenoma), [NCIT:C27527](http://purl.obolibrary.org/obo/NCIT_C27527) (Tubular Apocrine Adenoma), [NCIT:C43342](http://purl.obolibrary.org/obo/NCIT_C43342) (Apocrine Hidrocystoma), [NCIT:C7560](http://purl.obolibrary.org/obo/NCIT_C7560) (Sweat Gland Adenoma), [NCIT:C4174](http://purl.obolibrary.org/obo/NCIT_C4174) (Sebaceous Adenoma), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C41608](http://purl.obolibrary.org/obo/NCIT_C41608) (Endocrine-Stromal Cell) 53.12%
- [NCIT:C36117](http://purl.obolibrary.org/obo/NCIT_C36117) (Invasive Lesion) 53.12%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 53.12%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39301](http://purl.obolibrary.org/obo/NCIT_C39301) (CD4+/CD56+ Neoplastic Medium-Sized Cell))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39300](http://purl.obolibrary.org/obo/NCIT_C39300) (Precursor Natural Killer Cell))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39294](http://purl.obolibrary.org/obo/NCIT_C39294) (Schistosoma Hematobium Infection))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39293](http://purl.obolibrary.org/obo/NCIT_C39293) (Helicobacter Pylori Infection))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39291](http://purl.obolibrary.org/obo/NCIT_C39291) (HHV8 Infection))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39278](http://purl.obolibrary.org/obo/NCIT_C39278) (Thrombin/Protease-Activated Receptor Signaling Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39264](http://purl.obolibrary.org/obo/NCIT_C39264) (Angiogenesis Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39258](http://purl.obolibrary.org/obo/NCIT_C39258) (TPO Signaling Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39253](http://purl.obolibrary.org/obo/NCIT_C39253) (Interferon Signaling Modulation Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39250](http://purl.obolibrary.org/obo/NCIT_C39250) (Mucosal Healing Pathway))) 38.48%


